Evaluating Microarray Precision and Sensitivity
Author Information
Author(s): Holloway Andrew J, Oshlack Alicia, Diyagama Dileepa S, Bowtell David DL, Smyth Gordon K
Primary Institution: Ian Potter Foundation Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre
Hypothesis
Can a titration series of RNA samples effectively evaluate the precision and sensitivity of microarray technologies?
Conclusion
The study found that all microarray platforms demonstrated good precision and sensitivity, but highlighted the need for improved probe annotation.
Supporting Evidence
- All four microarray platforms showed satisfactory precision.
- Commercial platforms were superior for resolving differential expression at lower expression levels.
- The methodology allowed for a whole-array evaluation without needing to match probes across platforms.
- Cross-platform variability was mostly systematic rather than due to measurement variability.
Takeaway
The researchers mixed different amounts of two types of RNA to see how well different microarray platforms could measure gene expression. They found that some platforms did better than others.
Methodology
The study used a titration series of RNA samples and statistical analysis with non-linear regression to evaluate microarray platforms.
Potential Biases
Potential bias from probe-specific dye effects and the need for improved probe annotation.
Limitations
The study focused on the best-case scenario for each platform and may not reflect real-world laboratory variations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website